Staged-probability strategy of processing shotgun proteomic data to discover more functionally important proteins

Area of Science:

• Proteomics
• Mass Spectrometry (MS)
• Bioinformatics

Background:

• Biologically significant proteins (e.g., membrane receptors, signaling molecules) are often low in abundance.
• Traditional mass spectrometry analysis discards valuable data due to strict filtering for accurate protein identification.
• This leads to the loss of potential insights into crucial biological processes.

Purpose of the Study:

• To develop and validate a staged-probability strategy for assessing proteomic data.
• To improve the identification and utilization of low-abundance, functionally important proteins.
• To enhance biomarker discovery and therapeutic target screening.

Main Methods:

• Utilized cascade affinity fractionation (L2 and L3 layers) with Trans-Proteomic Pipeline software.
• Classified MS-based protein identifications into three probability stages (1.00-0.95, 0.95-0.50, 0.50-0.20).
• Assessed protein identification correctness rates at each probability stage.

Main Results:

• Significant volumes of proteomic data and functionally important proteins were found at lower probability stages (0.95-0.50 and 0.50-0.20).
• These lower probability identifications demonstrated acceptable correctness rates.
• Low-probability proteins identified in L2 were confirmed in L3, validating the strategy.

Conclusions:

• The staged-probability strategy provides a more comprehensive assessment of proteomic data quantity and quality.
• This approach is particularly beneficial for biomarker discovery and identifying novel therapeutic targets.
• It enables the recovery of valuable biological information previously excluded by stringent data filtering.